A look at what's coming to Contemporary OB/GYN® this week
The moves bring two new weapons to the toolbox for physicians fighting the pandemic.
Each year, the Medical Economics® team surveys their audience to find out what big challenges practitioners faced. By far, the top answer was “administrative burdens,” including staffing, prior authorizations and electronic health records (EHRs). Let's take a closer look at what these burdens entail to help physicians get ready for whatever challenges 2022 will bring.
A new Rutgers study indicates a connection between specific personal care products and lower levels of sex steroid hormones, which have a critical role in maintaining pregnancy and fetal development.
Coming soon
With the new year, Contemporary OB/GYN® kicks off a new season of its Pap Talk podcast on Wednesday, Jan. 5.
Coming soon
New research in the American Journal of Obstetrics and Gynecology showed a rise in community births during the COVID-19 pandemic, as many women thought a hospital delivery to be more dangerous. The data told a different story.
Coming soon
Buprenorphine use in pregnancy linked to decreased fetal breathing movements
May 18th 2024According to a poster presented at ACOG 2024, use of the synthetic opioid buprenorphine depressed fetal breathing in biophysical profile assessments, but had no significant impact on other factors like amniotic fluid index or fetal tone.
Read More
Laparoscopic RFA linked to enhanced pregnancy outcomes in uterine fibroid patients
May 18th 2024A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.
Read More
Identifying gaps in syphilis treatment and prenatal care among pregnant individuals
May 17th 2024Preventing congenital syphilis comes down to quick diagnosis and treatment of the infection in pregnancy, and the number of missed opportunities to do so in the United States continues to grow.
Read More